Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Malignant hyperthermia

Printer-friendly versionEmail this page to a friend
Contents of this page:

Alternative Names   

Hyperthermia - malignant; Hyperpyrexia - malignant

Definition    Return to top

Malignant hyperthermia is an inherited disease that causes a rapid rise in body temperature (fever) and severe muscle contractions when the affected person receives general anesthesia.

This condition is not the same as hyperthermia due to medical emergencies such as heat stroke.

Causes    Return to top

Malignant hyperthermia is an autosomal dominant trait, meaning it requires only one parent carrying the disease for a child to inherit the condition. It may be associated with muscular diseases such as multiminicore myopathy and central core disease.

One form of malignant hyperthermia is caused by a defect in the ryanodine receptor (RYR1) gene

Symptoms    Return to top

Malignant hyperthermia is often noted for the first time after a patient is given anesthesia during a surgical procedure.

Symptoms include:

Exams and Tests    Return to top

There may be a family history of malignant hyperthermia or unexplained death during anesthesia.

Tests that may be done include:

Treatment    Return to top

For an episode of malignant hyperthermia, acetaminophen (Tylenol) and a cooling blanket can help reduce fever. The use of a drug called dantrolene during episodes of malignant hyperthermia has greatly reduced the number of deaths.

Fluids given by IV and mouth, as well as certain medications, are essential for maintaining kidney function during an acute episode.

Support Groups    Return to top

Malignant Hyperthermia Association of the United States - www.mhaus.org

Outlook (Prognosis)    Return to top

Repeated episodes or untreated episodes can cause kidney failure. Untreated episodes can be fatal.

Possible Complications    Return to top

When to Contact a Medical Professional    Return to top

If you know that you or a member of your family has had problems with general anesthesia, or if you know you have a family history of malignant hyperthermia, be sure to notify both the surgeon and the anesthesiologist before having any surgery.

Prevention    Return to top

If you or anyone in your family has malignant hyperthermia, it is very important to tell your doctor, especially before having surgery with general anesthesia. The use of appropriate anesthetic medication can prevent the complications of malignant hyperthermia during surgery.

It is important to avoid stimulant drugs such as cocaine, amphetamine (speed) and ecstasy as they may produce malignant hyperthermia-like problems in susceptible individuals.

Genetic counseling is recommended for anyone with a family history of myopathy, muscular dystrophy, or malignant hyperthermia.

References    Return to top

Marx J. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 5th ed. St. Louis, Mo: Mosby; 2002:2000.

Update Date: 7/25/2007

Updated by: Chad Haldeman-Englert, MD, Division of Human Genetics, Children's Hospitalof Philadelphia, Philadelphia, PA. Review provided by VeriMed HealthcareNetwork.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2008, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.